Recro Pharma: Multiple Ways To Win From Potentially Transformative Near-Term Catalysts, While Crown-Jewel Asset Provides Downside Protection [Seeking Alpha]
Recro Pharma, Inc. (REPH)
Last recro pharma, inc. earnings: 11/8 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.recropharma.com
Company Research
Source: Seeking Alpha
Recro Pharma: Multiple Ways To Win From Potentially Transformative Near-Term Catalysts, While Crown-Jewel Asset Provides Downside ProtectionSummaryREPH’s share price has fallen ~25% from ~five weeks ago despite announcing positive news (resubmitting its NDA).REPH’s CDMO segment alone could be worth $23/share (or ~250% upside) based on recently-acquired peers.Its Acute Care segment could be worth another $7/share (or another ~100% upside) if IVM is approved and based on comparable products.REPH is led by a proven and incentivized CEO, while the last two companies under her leadership were ultimately sold.We believe REPH is substantially mispriced because it is miscategorized as a pure biotech by most investors/analysts and losses from Acute Care masks REPH’s highly-profitable, competitively-advantaged, and growing CDMO.
Show less
Read more
Impact Snapshot
Event Time:
REPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REPH alerts
High impacting Recro Pharma, Inc. news events
Weekly update
A roundup of the hottest topics